News & Updates

Children with prior use of carbapenem are at increased risk of developing Stenotrophomonas maltophilia bloodstream infection (BSI), suggests a study. In addition, admission to the paediatric intensive care unit (PICU) due to BSI and prior glycopeptide use are significantly associated with the mortality rate in patients with S. maltophilia BSIs

Treatment with cabergoline appears to reduce breast engorgement and other symptoms related to lactation in women following second-trimester abortion or pregnancy loss, as shown in a study.

Antibiotics, such as cefotaxime, ceftriaxone, and ciprofloxacin, demonstrate similar efficacy against spontaneous bacterial peritonitis (SBP), reports a study. Additionally, ciprofloxacin or ceftriaxone is not inferior to cefotaxime, which is the current standard for empirical therapy of community-acquired SBP.

New drug applications approved by US FDA as of 16-30 April 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Liraglutide therapy combined with aerobic exercise results in better glucose tolerance, beta cell function, and glucagon responses after losing weight, a study has shown.

The use of dexmedetomidine in the intensive care unit (ICU) appears to lower the risk of new-onset atrial fibrillation (AF) in patients, according to a study.